Dr. John Shepherd, MD

NPI: 1225031271
Total Payments
$881.93
2024 Payments
$44.83
Companies
24
Transactions
52
Medicare Patients
3,712
Medicare Billing
$901,704

Payment Breakdown by Category

Food & Beverage$842.59 (95.5%)
Education$39.34 (4.5%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $842.59 50 95.5%
Education $39.34 2 4.5%

Top Paying Companies

Company Total Records Latest Year
Otsuka America Pharmaceutical, Inc. $148.68 9 $0 (2019)
Amgen Inc. $106.57 6 $0 (2022)
Keryx Biopharmaceuticals, Inc. $78.37 5 $0 (2017)
Fresenius USA Marketing, Inc. $65.59 4 $0 (2018)
BAXTER HEALTHCARE $50.73 3 $0 (2017)
AstraZeneca Pharmaceuticals LP $49.76 3 $0 (2019)
GENZYME CORPORATION $41.22 2 $0 (2019)
GlaxoSmithKline, LLC. $35.30 2 $0 (2022)
AKEBIA THERAPEUTICS INC $34.50 2 $0 (2024)
SANOFI-AVENTIS U.S. LLC $30.67 2 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2024 $44.83 2 AKEBIA THERAPEUTICS INC ($24.61)
2022 $51.87 3 Amgen Inc. ($19.25)
2021 $110.09 6 Alexion Pharmaceuticals, Inc. ($20.49)
2020 $19.97 1 Lundbeck LLC ($19.97)
2019 $174.44 11 Otsuka America Pharmaceutical, Inc. ($66.16)
2018 $146.05 9 Otsuka America Pharmaceutical, Inc. ($32.21)
2017 $334.68 20 Keryx Biopharmaceuticals, Inc. ($78.37)

All Payment Transactions

52 individual payment records from CMS Open Payments — Page 1 of 3

Date Company Product Nature Form Amount Type
12/31/2024 Abbott Laboratories ETERNA (Device) Food and Beverage In-kind items and services $20.22 General
Category: Neuromodulation
12/05/2024 AKEBIA THERAPEUTICS INC Vafseo (Drug) Education In-kind items and services $24.61 General
Category: Nephrology
11/14/2022 Vifor Pharma, Inc. Veltassa (Drug), Korsuva Food and Beverage In-kind items and services $15.25 General
Category: Hyperkalemia
05/19/2022 Amgen Inc. Parsabiv (Drug) Food and Beverage In-kind items and services $19.25 General
Category: Nephrology
02/02/2022 GlaxoSmithKline, LLC. BENLYSTA (Biological) Food and Beverage In-kind items and services $17.37 General
Category: IMMUNOLOGY
09/14/2021 GlaxoSmithKline, LLC. BENLYSTA (Biological) Food and Beverage In-kind items and services $17.93 General
Category: IMMUNOLOGY
08/31/2021 Amgen Inc. Parsabiv (Drug) Food and Beverage In-kind items and services $16.10 General
Category: Nephrology
08/10/2021 Takeda Pharmaceuticals U.S.A., Inc. GATTEX (Drug) Food and Beverage In-kind items and services $18.39 General
Category: INTERNAL MEDICINE
08/09/2021 Aurinia Pharma U.S., Inc. LUPKYNIS (Drug) Food and Beverage In-kind items and services $17.23 General
Category: LUPUS NEPHRITIS
05/18/2021 OPKO Pharmaceuticals, LLC RAYALDEE (Drug) Food and Beverage In-kind items and services $19.95 General
Category: NEPHROLOGY
04/27/2021 Alexion Pharmaceuticals, Inc. Ultomiris (Drug) Food and Beverage In-kind items and services $20.49 General
Category: Immunology
02/18/2020 Lundbeck LLC NORTHERA (Drug) Food and Beverage Cash or cash equivalent $19.97 General
Category: NEUROLOGY
12/10/2019 Otsuka America Pharmaceutical, Inc. JYNARQUE (Drug) Food and Beverage In-kind items and services $16.05 General
Category: NEPHROLOGY
09/17/2019 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $18.16 General
Category: Cardiovascular and Metabolism
09/10/2019 Otsuka America Pharmaceutical, Inc. SAMSCA (Drug), JYNARQUE Food and Beverage In-kind items and services $15.01 General
Category: NEPHROLOGY
08/13/2019 Horizon Therapeutics plc KRYSTEXXA (Biological) Food and Beverage In-kind items and services $15.77 General
Category: KRYSTEXXA
07/16/2019 GENZYME CORPORATION FABRY-DISEASE (Drug) Food and Beverage In-kind items and services $19.00 General
07/03/2019 Otsuka America Pharmaceutical, Inc. SAMSCA (Drug) Food and Beverage In-kind items and services $18.35 General
Category: NEPHROLOGY
04/30/2019 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $11.58 General
Category: Cardiovascular and Metabolism
03/20/2019 Novartis Pharmaceuticals Corporation AFINITOR (Drug) Food and Beverage In-kind items and services $13.86 General
Category: ONCOLOGY
02/12/2019 Otsuka America Pharmaceutical, Inc. JYNARQUE (Drug) Food and Beverage In-kind items and services $16.75 General
Category: NEPHROLOGY
02/05/2019 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $20.02 General
Category: Cardiovascular and Metabolism
01/16/2019 AKEBIA THERAPEUTICS INC AURYXIA (Drug) Food and Beverage Cash or cash equivalent $9.89 General
Category: NEPHROLOGY
12/04/2018 Amgen Inc. Parsabiv (Biological) Food and Beverage In-kind items and services $19.50 General
Category: Nephrology
11/13/2018 Shire North American Group Inc NATPARA (Drug) Food and Beverage In-kind items and services $18.07 General
Category: INTERNAL MEDICINE

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 10 664 1,300 $454,990 $148,446
2022 13 850 1,671 $568,550 $194,341
2021 13 997 2,159 $720,140 $241,937
2020 13 1,201 3,060 $1.1M $316,980
Total Patients
3,712
Total Services
8,190
Medicare Billing
$901,704
Procedure Codes
49

All Medicare Procedures & Services

49 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
90960 Dialysis services, 4 or more physician visits per month (20 years or older) Office 2023 142 250 $187,500 $68,306 36.4%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 138 447 $82,695 $26,249 31.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 186 258 $33,540 $14,917 44.5%
90966 Home dialysis services per month (20 years or older) Office 2023 30 59 $44,250 $13,188 29.8%
90935 Hemodialysis procedure with physician evaluation Facility 2023 64 176 $48,400 $9,237 19.1%
90961 Dialysis services, 2-3 physician visits per month (20 years or older) Office 2023 30 33 $24,750 $7,678 31.0%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 34 34 $14,620 $4,284 29.3%
90962 Dialysis services, 1 physician visit per month (20 years or older) Office 2023 15 18 $13,500 $2,879 21.3%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 14 14 $5,460 $1,664 30.5%
81000 Manual urinalysis test with examination using microscope, non-automated Office 2023 11 11 $275.00 $43.34 15.8%
90960 Dialysis services, 4 or more physician visits per month (20 years or older) Office 2022 145 350 $262,500 $99,297 37.8%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 162 524 $96,940 $28,835 29.7%
90966 Home dialysis services per month (20 years or older) Office 2022 41 70 $52,500 $15,439 29.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 196 243 $31,590 $14,389 45.5%
90961 Dialysis services, 2-3 physician visits per month (20 years or older) Office 2022 36 43 $32,250 $10,131 31.4%
90935 Hemodialysis procedure with physician evaluation Facility 2022 80 131 $36,025 $7,337 20.4%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 48 49 $21,070 $7,049 33.5%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 41 41 $15,990 $4,592 28.7%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 36 40 $7,400 $3,569 48.2%
90945 Dialysis procedure including 1 evaluation Facility 2022 14 35 $7,700 $2,365 30.7%
90970 Dialysis services, per day, less than full month service (20 years or older) Office 2022 11 102 $2,550 $775.31 30.4%
99212 Established patient office or other outpatient visit, 10-19 minutes Facility 2022 14 16 $1,360 $456.21 33.5%
81000 Manual urinalysis test with examination using microscope, non-automated Office 2022 26 27 $675.00 $107.10 15.9%
90960 Dialysis services (4 or more physician visits per month), patient 20 years of age and older Office 2021 217 455 $341,250 $122,153 35.8%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 191 726 $134,310 $40,454 30.1%

About Dr. John Shepherd, MD

Dr. John Shepherd, MD is a Nephrology healthcare provider based in Pinehurst, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1225031271.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Shepherd, MD has received a total of $881.93 in payments from pharmaceutical and medical device companies, with $44.83 received in 2024. These payments were reported across 52 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($842.59).

As a Medicare-enrolled provider, Shepherd has provided services to 3,712 Medicare beneficiaries, totaling 8,190 services with total Medicare billing of $901,704. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.

Practice Information

  • Specialty Nephrology
  • Location Pinehurst, NC
  • Active Since 05/23/2005
  • Last Updated 12/01/2009
  • Taxonomy Code 207RN0300X
  • Entity Type Individual
  • NPI Number 1225031271

Products in Payments

  • SAMSCA (Drug) $115.88
  • Auryxia (Drug) $78.37
  • Parsabiv (Biological) $71.22
  • LOKELMA (Drug) $49.76
  • Velphoro (Drug) $49.05
  • FABRY-DISEASE (Drug) $41.22
  • Veltassa (Drug) $36.38
  • Parsabiv (Drug) $35.35
  • BENLYSTA (Biological) $35.30
  • JYNARQUE (Drug) $32.80
  • RENVELA (Drug) $30.67
  • Renal - PD (Device) $28.27
  • Vafseo (Drug) $24.61
  • Renal - Acute (Device) $22.46
  • Ultomiris (Drug) $20.49
  • ETERNA (Device) $20.22
  • NORTHERA (Drug) $19.97
  • RAYALDEE (Drug) $19.95
  • GATTEX (Drug) $18.39
  • NATPARA (Drug) $18.07

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Nephrology Doctors in Pinehurst